Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Current understanding of neurofibromatosis type 1, 2, and schwannomatosis
R Tamura - International journal of molecular sciences, 2021 - mdpi.com
Neurofibromatosis (NF) is a neurocutaneous syndrome characterized by the development of
tumors of the central or peripheral nervous system including the brain, spinal cord, organs …
tumors of the central or peripheral nervous system including the brain, spinal cord, organs …
The diagnosis and management of neurofibromatosis type 1
KI Ly, JO Blakeley - Medical Clinics, 2019 - medical.theclinics.com
Neurofibromatosis (NF) type 1 (NF1), NF type 2 (NF2), and schwannomatosis constitute a
group of autosomal dominant tumor suppressor syndromes that predispose to benign and …
group of autosomal dominant tumor suppressor syndromes that predispose to benign and …
Birth incidence and prevalence of tumor‐prone syndromes: estimates from a UK family genetic register service
DG Evans, E Howard, C Giblin, T Clancy… - American journal of …, 2010 - Wiley Online Library
Dominantly inherited tumor-prone syndromes are a significant health burden, but disease-
related morbidity can be reduced and life expectancy increased by a GR type approach …
related morbidity can be reduced and life expectancy increased by a GR type approach …
[HTML][HTML] Clinical and genetic aspects of neurofibromatosis 1
K Jett, JM Friedman - Genetics in Medicine, 2010 - Elsevier
Neurofibromatosis 1 is an autosomal dominant disorder characterized by multiple café-au-
lait spots, axillary and inguinal freckling, multiple cutaneous neurofibromas, and iris Lisch …
lait spots, axillary and inguinal freckling, multiple cutaneous neurofibromas, and iris Lisch …
Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for …
H Kehrer-Sawatzki, DN Cooper - Human genetics, 2022 - Springer
Abstract Neurofibromatosis type 1 (NF1) is the most frequent disorder associated with
multiple café-au-lait macules (CALM) which may either be present at birth or appear during …
multiple café-au-lait macules (CALM) which may either be present at birth or appear during …
High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p. Arg1809 …
K Rojnueangnit, J **e, A Gomes, A Sharp… - Human …, 2015 - Wiley Online Library
ABSTRACT Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders,
affecting 1: 3,000 worldwide. Identification of genotype–phenotype correlations is …
affecting 1: 3,000 worldwide. Identification of genotype–phenotype correlations is …
NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype
Abstract In 5‐10% of patients, neurofibromatosis type 1 (NF1) results from microdeletions
that encompass the entire NF1 gene and a variable number of flanking genes. Two recurrent …
that encompass the entire NF1 gene and a variable number of flanking genes. Two recurrent …
NF1 Molecular Characterization and Neurofibromatosis Type I Genotype–Phenotype Correlation: The French Experience
ABSTRACT Neurofibromatosis type 1 (NF 1) affects about one in 3,500 people in all ethnic
groups. Most NF 1 patients have private loss‐of‐function mutations scattered along the NF 1 …
groups. Most NF 1 patients have private loss‐of‐function mutations scattered along the NF 1 …
Neurofibromin and suppression of tumorigenesis: beyond the GAP
Abstract Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disease and one
of the most common inherited tumor predisposition syndromes, affecting 1 in 3000 …
of the most common inherited tumor predisposition syndromes, affecting 1 in 3000 …
Noonan syndrome: clinical aspects and molecular pathogenesis
M Tartaglia, G Zampino, BD Gelb - Molecular syndromology, 2010 - karger.com
Noonan syndrome (NS) is a relatively common, clinically variable and genetically
heterogeneous developmental disorder characterized by postnatally reduced growth …
heterogeneous developmental disorder characterized by postnatally reduced growth …